Participants took the following medications for diabetes: Metformin (62.5%), Repaglinide (31.25%), DPP-4 inhibitor (31.25%), Sulfonylurea (18.75%), GLP -1 (6.25%), SGLT2i (6.25%), insulin (6.25%). Here, DPP4 is linked to diabetes mellitus.